The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysisMaarten M.J. Wijnenga, Martin J. van den Bent, Pim J. French et al.|Neuro-Oncology|2017Cited by 330
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteriaC. Mircea S. Tesileanu, Martin J. van den Bent, Maarten M.J. Wijnenga et al.|Neuro-Oncology|2019Cited by 213
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation studyMartinus P. G. Broen, Martin J. van den Bent, Marion Smits et al.|Neuro-Oncology|2018Cited by 205
Prevalence and Implications of<i>TERT</i>Promoter Mutation in Uveal and Conjunctival Melanoma and in Benign and Premalignant Conjunctival Melanocytic LesionsAnna E. Koopmans, Robert M. Verdijk, Kimberley Ober et al.|Investigative Ophthalmology & Visual Science|2014Cited by 91
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladderThomas van Doeveren, Joost L. Boormans, Andrew S. Mason et al.|International Journal of Cancer|2020Cited by 24